Nonhypoglycemic drug reactions of agents used to treat diabetes.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Endocrinology and metabolism clinics of North America (Print)

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0889-8529(05)70165-1PMID 11149163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Troglitazone-Induced Pulmonary Edema—Reply

  2000cited by this paper
• Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report

  2000cited by this paper
• Ruptured solitary iliac artery aneurysm presenting as a seizure disorder.

  2000cited by this paper
• Hepatic Failure in a Patient Taking Rosiglitazone

  2000cited by this paper
• Troglitazone-induced pulmonary edema.

  2000cited by this paper
• Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.

  1999cited by this paper
• Pulmonary edema associated with troglitazone therapy.

  1999cited by this paper
• Effect of thiazolidinediones on expression of UCP2 and adipocyte markers in human PAZ6 adipocytes

  1999cited by this paper
• Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

  1999cited by this paper
• Significant weight gain with rezulin therapy.

  1999cited by this paper
• Acarbose-associated hepatotoxicity.

  1998cited by this paper
• The vacA Genotypes in 167 Isolates From Japanese Patients With Either Peptic Ulcers or Non-ulcer Dyspepsia

  1998cited by this paper
• Acarbose-induced hepatic injury.

  1998cited by this paper
• The sulfonylurea controversy: more questions from the heart.

  1998cited by this paper
• Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.

  1997cited by this paper
• Potentially Lethal Ileus Associated With Acarbose Treatment for NIDDM

  1997cited by this paper
• "Glitazones", a prospect for non-insulin-dependent diabetes.

  1997cited by this paper
• Acarbose-induced acute severe hepatotoxicity.

  1997cited by this paper
• Hepatic Injury Caused by Acarbose

  1996cited by this paper
• Ileus: A Rare Side Effect of Acarbose

  1996cited by this paper
• Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

  1995cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

  1994cited by this paper
• The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus

  1994cited by this paper
• Comparative Tolerability Profiles of Oral Antidiabetic Agents

  1994cited by this paper
• Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• Adverse Effects of Exogenous Insulin

  1993cited by this paper
• Insulin-induced cardiac failure.

  1985cited by this paper
• The renal metabolism of insulin

  1984cited by this paper
• Ephedrine: a new treatment for diabetic neuropathic oedema.

  1983cited by this paper
• Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

  1980cited by this paper
• Use of Dexamethasone in Treatment of Insulin Lipoatrophy

  1977cited by this paper
• Amino Acid Sequences of Proinsulins and Intermediates

  1972cited by this paper
• A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP)

  1972cited by this paper
• Diabetes mellitus: theory and practice

  1970cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper

• LC-MS–MS in MRM Mode for Detection and Structural Identification of Synthetic Hypoglycemic Drugs Added Illegally to ‘Natural’ Anti-Diabetic Herbal Products

  2009cites this paper
• Treatment of the Metabolic Disturbances Caused by Antipsychotic Drugs

  2004cites this paper
• Anti-obesity drug development

  2002cites this paper